Effects of aluminum-salt, CpG and emulsion adjuvants on the stability and immunogenicity of a virus-like particle displaying the SARS-CoV-2 receptor-binding domain (RBD)
ABSTRACTSecond-generation COVID-19 vaccines with improved immunogenicity (e.g., breadth, duration) and availability (e.g., lower costs, refrigerator stable) are needed to enhance global coverage. In this work, we formulated a clinical-stage SARS-CoV-2 receptor-binding domain (RBD) virus-like particl...
Saved in:
Main Authors: | Ozan S. Kumru (Author), Sakshi Bajoria (Author), Kawaljit Kaur (Author), John M. Hickey (Author), Greta Van Slyke (Author), Jennifer Doering (Author), Katherine Berman (Author), Charles Richardson (Author), Hans Lien (Author), Harry Kleanthous (Author), Nicholas J. Mantis (Author), Sangeeta B. Joshi (Author), David B. Volkin (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvants
by: Sakshi Bajoria, et al.
Published: (2022) -
Effect of Calcium Carbonate Encapsulation on the Activity of Orally Administered CpG Oligonucleotides
by: Neslihan Kayraklioglu, et al.
Published: (2017) -
Genome-wide identification of methylated CpG sites in nongenital cutaneous warts
by: Laith N. AL-Eitan, et al.
Published: (2020) -
CpG Oligodeoxynucleotides for Anticancer Monotherapy from Preclinical Stages to Clinical Trials
by: Zhongkun Zhang, et al.
Published: (2021) -
In Vivo TLR9 Inhibition Attenuates CpG-Induced Myocardial Dysfunction
by: O. Boehm, et al.
Published: (2013)